New $46M grant allows the University of Oxford and Boston Children’s Hospital to lead Genetic Medicines Hub within ARIA ecosystem
The University of Oxford and Boston Children’s Hospital, with collaboration from The Jackson Laboratory and N=1 Collaborative, have been selected to establish a new Genetic Medicines Hub, one of six research hubs within the Aligning Research to Impact Autism (ARIA) ecosystem.
Read original article on The Medical News →Related news
-
A weight-loss drug eased knee arthritis pain in two major trials
United Kingdom
-
Brain's 'cleanup' molecule could aid recovery after stroke
United Kingdom
-
Blood proteins that may predict brain and cardiovascular health issues identified
United Kingdom
-
Researchers detect signs of neuronal damage in the earliest stage of Huntington's disease
United Kingdom
-
Patient comfort with AI-driven health care hinges on provider oversight
United Kingdom
-
Experimental drug eliminates 75% of aggressive pancreatic tumors and enhances immune system memory
United Kingdom
-
Gas prices dip below $4 but inflation remains stubbornly high
United States
-
Martian Volcanic Discovery Could Be ‘Smoking Gun’ in Search for Life
United Kingdom